ArticlePloS one2012

Dasatinib inhibits CXCR4 signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12.

Alison M McCaig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.